Status
Conditions
Treatments
About
2.1 Main objective: To observe the short-term and long-term recurrence rates of various endoscopic minimally invasive treatment methods for internal hemorrhoids and different time points of endoscopic minimally invasive treatment for internal hemorrhoids in patients with grade I-III internal hemorrhoids
2.2 Secondary objective: To observe the safety and efficacy of endoscopic minimally invasive treatment of internal hemorrhoids
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
2, grade I-III internal hemorrhoids with symptoms related to internal hemorrhoids
Exclusion criteria
Degree of internal hemorrhoids with incarceration, thrombosis, erosion, infection, etc. (3) patients with severe systemic diseases could not tolerate endoscopic treatment; (4) accompanied by crissum infectious disease, anal fistula, and inflammatory bowel disease activity, etc.; (5) in menstrual period, pregnancy and puerperium, (6) patients with sclerotherapy allergy; (7) function of blood coagulation disorder or are using anticoagulant drugs.
Patients with a history of allergy to narcotic drugs
Patients who were deemed by the investigator to be ineligible for participation in the trial
900 participants in 3 patient groups
Loading...
Central trial contact
Zheng Zewei Zewei Zheng, Professor; Ying Zhu Ying Zhu, Professor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal